Home » Applications » Theranostics

Theranostic imaging for translational insight

Visualize therapeutic agents directly, so you can understand biological response, quantify distribution, and make translational decisions with confidence.

MILabs is the go-to imaging partner for preclinical theranostic research, enabling direct, quantitative imaging of therapeutic and diagnostic isotopes within the same biological system. With proven capability across the widest range of theranostic agents and energies, MILabs helps researchers evaluate emerging strategies early, reduce uncertainty, and translate discoveries toward real-world impact with clarity and confidence.

Discover all other applications.

MILabs equipment for theranostic applications

Study imaging and therapeutic phases of the same targeted agent, so you can optimize dosing, quantify distribution, and translate with confidence.
MILabs imaging systems support ultra-high-sensitivity, ultra-high-resolution molecular imaging across the broadest range of theranostic isotopes and energies. This enables direct visualization of targeted agents in both their diagnostic and therapeutic forms, without relying on surrogate tracers. By imaging matched isotope pairs within the same biological system, researchers can generate aligned, quantitative datasets that strengthen dosimetry, biological interpretation, and translational decision-making.
MILabs imaging systems support ultra-high-sensitivity, ultra-high-resolution molecular imaging across a wide range of isotopes and energies

Benefits of MILabs systems for theranostic research

Direct imaging of therapeutic isotopes

See theranostic agents where they act, so you can quantify delivery and biological response accurately.

MILabs platforms support a huge range of alpha-, beta-, and Auger-emitting isotopes at sub-millimeter resolution. This enables precise localization and quantification of therapeutic agents, eliminating the uncertainty introduced by surrogate tracers and supporting stronger translational insight. MILabs offers true broadband imaging, with the widest range of energies to be ready for the next theranostic agent that nobody ever thought of, yet.

Simultaneous multi-isotope molecular imaging

Compare diagnostic and therapeutic behavior within the same model, so you can reduce variability and improve study efficiency.
MILabs systems support simultaneous imaging of multiple isotopes across the broadest energy range. This allows researchers to study comparative biodistribution, pharmacokinetics, and biological response within a single subject, strengthening statistical power while reducing animal usage.
Discover Multimodality

High sensitivity and resolution for biological response assessment

Detect subtle changes in biological systems, so you can evaluate response earlier and with greater confidence.
By combining ultra-high sensitivity with ultra-high spatial resolution, MILabs imaging enables visualization of small changes in tracer uptake and distribution over time. MILabs offers the highest sensitivity collimators in the market. This supports early assessment of therapeutic response and more informed optimization of dosing and agent design.

Hear from the experts

Targeting tumors from the inside

Name and title - Dr Bart Cornelissen, Leader of the Radiopharmaceuticals and Molecular Imaging Group at the University of Oxford

We spoke to Dr Bart Cornelissen, Leader of the Radiopharmaceuticals and Molecular Imaging Group at the University of Oxford, about his research focusing on the development of radiolabeled compounds. He explained the importance of imaging SPECT and PET radioisotopes using VECTor PET/SPECT/CT.
Discover more

Targeted alpha therapy

Name and title - Professor Vesna Sossi, University of British Columbia, Vancouver

“We are using the MILabs VECTor PET/SPECT/CT to accelerate our theranostics research program. We are focused on imaging TAT. Attractive alpha emitters like ²¹¹At/²⁰⁹At and ²²⁵Ac expose in vivo imagers to a broad range of gamma energies – up to 750 keV for ²⁰⁹At and 440 keV for ²¹³Bi. These are challenging to image with traditional PET, which only detects 511 keV photons in coincidence. With traditional SPECT, one has also a lot of troubles because of resolution losses and breakthrough from high-energy gamma rays. To our knowledge, VECTor is the only system that is suited to handling all targeted radiotherapy imaging and dosimetry applications.”
Discover more

Want to know what MILabs can do for you?

Request more information